Desalegn Markos Shifti, Erin Pitt, Lesley Versteegh, Rani Scott Farmer, Catherine J Hornung, Victoria Gibson, Diane Maresco-Pennisi, Shyamali C Dharmage, Anne B Chang, Jennifer J Koplin
{"title":"Mapping the Burden and Risk Factors of Allergic Diseases and Asthma Among Aboriginal and Torres Strait Islander People: A Scoping Review.","authors":"Desalegn Markos Shifti, Erin Pitt, Lesley Versteegh, Rani Scott Farmer, Catherine J Hornung, Victoria Gibson, Diane Maresco-Pennisi, Shyamali C Dharmage, Anne B Chang, Jennifer J Koplin","doi":"10.1111/cea.70138","DOIUrl":null,"url":null,"abstract":"<p><p>Allergic diseases and asthma are significant public health concerns in Australia and globally. However, comprehensive data on the burden among Aboriginal and Torres Strait Islander people are scarce. This scoping review aimed to systematically map existing evidence on the burden and risk factors of allergic diseases and asthma among Aboriginal and Torres Strait Islander people. MEDLINE, Scopus, Embase and Web of Science Core Collection were systematically searched through March 2024. We included studies that reported allergic diseases and asthma among Aboriginal and Torres Strait Islander people. Study characteristics and outcome data were tabulated and evidence was synthesised narratively. Fifty-four studies involving an estimated 176,792 Aboriginal and Torres Strait Islander people were included. These studies reported on asthma (n = 48), eczema (n = 10), allergic rhinitis (n = 6), atopy (n = 3), mixed allergies (combining food, drug and other undefined allergies) (n = 2), and anaphylaxis (n = 1). No studies solely investigating food allergies were found. The majority of studies were from Western Australia (WA, n = 15) and the Northern Territory (NT, n = 14). Estimates of allergy prevalence varied widely between studies, with eczema ranging from 2.0% to 44.4%, allergic rhinitis from 0.2% to 37.3%, and atopy from 1.7% to 36.4%. Asthma prevalence ranged from 2.0% to 50.5%. Risk factors for asthma included exposure to smoke and lower socioeconomic status, while a family history of allergy was associated with an increased risk of allergic rhinitis. In conclusion, Aboriginal and Torres Strait Islander people face a potentially significant burden of allergic diseases and asthma, yet they remain underrepresented in research. Culturally responsive studies are needed to address this substantial evidence gap.</p>","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Allergy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/cea.70138","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Allergic diseases and asthma are significant public health concerns in Australia and globally. However, comprehensive data on the burden among Aboriginal and Torres Strait Islander people are scarce. This scoping review aimed to systematically map existing evidence on the burden and risk factors of allergic diseases and asthma among Aboriginal and Torres Strait Islander people. MEDLINE, Scopus, Embase and Web of Science Core Collection were systematically searched through March 2024. We included studies that reported allergic diseases and asthma among Aboriginal and Torres Strait Islander people. Study characteristics and outcome data were tabulated and evidence was synthesised narratively. Fifty-four studies involving an estimated 176,792 Aboriginal and Torres Strait Islander people were included. These studies reported on asthma (n = 48), eczema (n = 10), allergic rhinitis (n = 6), atopy (n = 3), mixed allergies (combining food, drug and other undefined allergies) (n = 2), and anaphylaxis (n = 1). No studies solely investigating food allergies were found. The majority of studies were from Western Australia (WA, n = 15) and the Northern Territory (NT, n = 14). Estimates of allergy prevalence varied widely between studies, with eczema ranging from 2.0% to 44.4%, allergic rhinitis from 0.2% to 37.3%, and atopy from 1.7% to 36.4%. Asthma prevalence ranged from 2.0% to 50.5%. Risk factors for asthma included exposure to smoke and lower socioeconomic status, while a family history of allergy was associated with an increased risk of allergic rhinitis. In conclusion, Aboriginal and Torres Strait Islander people face a potentially significant burden of allergic diseases and asthma, yet they remain underrepresented in research. Culturally responsive studies are needed to address this substantial evidence gap.
期刊介绍:
Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field.
In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical & Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part.